Authors


Sandra Smith, RN, MSN, AOCN

Latest:

Accelerating Clinical Trial Activation

The activation of each clinical trial involves hundreds of tasks, along with many dependencies and handoffs, some of which may be automated, but many require manual processes.


Shivaji Bote

Latest:

Establishing Metrics and Standardization for Non-CRF Data in EDC

While Case Report Forms are a main contributor to collected data, non-CRF data such as core laboratory data and central imaging can be critical to any clinical study.


Karen Maduschke

Latest:

Advancing ICU Care with eConsent

Complicated process of consenting ICU patients can be simplified with a well-designed eConsent platform.


Rob Verheul

Latest:

Is Trust the Secret Ingredient for Digital Product Success?

To rebuild trust, companies should focus on transparent, neutral content incorporating medical expertise and regularly seeking HCP feedback.



Christopher Varner

Latest:

Virtual Trials Save the Day

Virtual trials tools are usually selected early in the protocol development stage, however, due to the COVID-19 crisis, regulators are encouraging sponsors to consider integrating virtual elements into clinical trials already in progress.


Research Professionals Ltd

Latest:

De-risking DCTs with Quality Systems

Webinar Date/Time: Wed, Nov 30, 2022 10:00 AM EST



Faith Holmes, MD

Latest:

Steps Toward Diversity in Clinical Trials: Building Authentic Trust

Building authentic trust lays at the heart of creating more patient-centric trials.


Jennifer Krohn

Latest:

Harnessing the Power of Scientific Surveillance

Statistical methods used via this technique in centralized monitoring.


Miranda K. Brainard; Carrie Smith, RN; Nashat Gabrail, MD

Latest:

A Cross-Sectional Study of Patient Perspectives on Clinical Trial Participation in a Large Community-Based Research Facility

An overview of patient perceptions of cancer clinical trials and the consent process among those who are currently enrolled in, or who recently completed, a cancer clinical trial.




Katrien Lemmens

Latest:

Impact of COVID-19 on Phase I Clinical Activities

Life sciences companies challenged by need to minimize health risks without sacrificing data quality during pandemic.


Leandra Plappert

Latest:

COVID-19 Will Have a Heterogeneous Impact on Clinical Trials, Biopharmas

A discussion of how the coronavirus pandemic will have a multitude of impacts on the conduct of trials, as well as on the industry itself.


CISCRP Team

Latest:

Remembering That TIME Magazine Issue; Celebrating Progress in Patient Engagement

Looking to the past reminds industry of great strides taken in clinical research for patients.


Flatiron

Latest:

Unlocking Oncology Insights - Innovations in Evidence Generation With RWE Solutions

The rapid evolvement of precision oncology requires real-world data generated at a scale that unlocks insights that can not be provided from clinical trial evidence. Machine learning and large language models can be used to quickly identify information, supporting custom integrated real-world evidence solutions to make informed decisions.


David Gustafsson

Latest:

eSource Interoperability Between EHR and EDC

Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.



Erica Smith, PhD

Latest:

Using Machine Learning to Predict Placebo Response and Increase Clinical Trial Success

A look at the prevalence of placebo response in clinical trials and how advanced solutions can mitigate the risk it poses to drug development.


Michael Cohen

Latest:

Aligning Patient Burden with Planetary Burden

How making trial participation easier can reduce the impact on the environment.


Jane Myles

Latest:

How DCT Technology Can Enable Follow-up Clinical Studies

Research can reveal vital information about treatments in the long run.


Linda Ashmore

Latest:

Improving Diversity in Clinical Trial Volunteer Participation by Addressing Racial and Ethnic Representation Among the Clinical Research Workforce

2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.


Sarah Taylor

Latest:

eSource Interoperability Between EHR and EDC

Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.




Roberta Ferreira

Latest:

Clinical Study Audits: The Quality Management Approach

Advancing risk-based auditing one step further by identifying the underlying process deficiencies to enable improved corrective and preventive actions.


Robert A. DiCicco, PharmD

Latest:

Accelerating Clinical Trial Design and Operations

Fully-integrated, component-based CDMS offers flexibility, customization, and efficiency.


Dan Gebow, PhD

Latest:

Transforming Clinical Event Adjudication in the Era of COVID-19

There's no one-size-fits-all approach during the COVID-19 pandemic


Gary A. Kaplan

Latest:

Where Do We Go From Here?

Lessons from six months of conducting clinical trials during the COVID-19 pandemic

© 2024 MJH Life Sciences

All rights reserved.